Nine Cambridge scientists among the new 2022 Fellows announced by the Royal Society
10 May 2022The nine Cambridge researchers were all selected for their exceptional contributions to science.
The nine Cambridge researchers were all selected for their exceptional contributions to science.
New research reveals how increasing brain stiffness as we age causes brain stem cell dysfunction, and demonstrates new ways to reverse older stem cells to a younger, healthier state.
There are many challenges facing people with spinal cord injury – and walking again is often the least of their problems. Cambridge research could help patients take control of their lives once more.
A protein activated by vitamin D could be involved in repairing damage to myelin in people with multiple sclerosis (MS), according to new research from the University of Cambridge. The study, published today in the Journal of Cell Biology, offers significant evidence that vitamin D could be a possible treatment for MS in the future.
Like conducting an errant orchestra to play together, researchers are guiding processes that go awry in multiple sclerosis to repair themselves.
Today, we commence a month-long focus on research on stem cells. To begin, Professors Austin Smith and Robin Franklin discuss how Cambridge scientists are helping to provide a stream of new knowledge about how our bodies are made and maintained, and how stem cells can fulfil the promise of being one of medical research’s great hopes.
Multiple sclerosis treatments that repair damage to the brain could be developed thanks to new research.
Cambridge researchers developing new therapies as part of a collaborative programme with industry.
Researchers have shown it is possible to restore co-ordinated limb movement in dogs with severe spinal cord injury (SCI).
Proof of principle study suggests the age-associated decline of the remyelination process is reversible.